SynthesisJournal of robotic surgery2025
Clinical effectiveness of enhanced recovery after surgery in robotic prostatectomy: a meta-analysis of systematic review.
Synthesis in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retracted
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enhanced Recovery After Surgery (ERAS) bundles coordinate multimodal perioperative care to optimize outcomes. Although widely used in radical cystectomy, their role in robot-assisted radical prostatectomy (RARP) is less well defined. In line with PRISMA, literature database were searched for studies comparing ERAS or modified ERAS pathways with conventional care in RARP. Using RevMan, random-effects models generated pooled estimates, reported as weighted mean differences (WMDs), odds ratios (ORs), and 95% confidence intervals (CIs). Seven studies comprising 848 patients (439 ERAS; 409 standard care) met inclusion criteria. ERAS reduced hospital length of stay by 1.02 days (95% CI 0.29-1.74; P = 0.006) and accelerated gastrointestinal recovery, including earlier ambulation (WMD 0.68 days; 95% CI 0.11-1.26; P = 0.02). Time to first flatus and defecation was also shorter (flatus: WMD 1 day; 95% CI 0.65-1.35; P < 0.001; defecation: WMD 0.29 days; 95% CI 0.16-0.42; P < 0.001). No significant differences were observed for complication rates. ERAS protocols in RARP promote faster recovery, particularly gastrointestinal function, without increasing complications. However, as early discharge is now standard in many centers, their added value may be limited. Future studies should determine which ERAS components provide the greatest benefit, especially in high-risk patients requiring structured perioperative care.
Indexed as
Identifiers
41364131What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.